Companies - Fagron


Price: Price

€ 15,80

Change

€ -0,14

Change %

-0,88%

Open

€ 15,94

High

€ 15,96

Low

€ 15,77

Volume

46.634
Profile: Profile

Fagron is specialized in the development, sale and distribution of personal care products and services intended for professionals in the health sector (doctors, pharmacists, dentists, hospitals, nursing homes, etc.).

Site

http://www.fagron.com

Industry

Pharmaceutical

Description

Companies in the pharmaceutical industry develop and sell drugs. In addition, licenses on newly developed drugs are sold to other companies. Medications are strictly supervised by different supervisors. This, and the complex process of developing new drugs results in the long development time before a product makes it to the market. Companies that develop new drugs benefit from long-term protection of their products through patents. This allows them to make money on a new drug.
Key figures (2020): The ratios below are calculated using the last known share price and the last known company financials.

Ratios per share

Price to Earnings

19,111

Price to Earnings (3 years)

23,871

Price to Earnings (5 years)

33,649

Price to earnings growth

0,458

Price/cashflow

19,111

Price/net cashflow

-

Price/book value

-

Price to sales

2,044

Ratios for dividend

Dividend yield

1,14%

Pay out

21,77%

Valuation ratios

Market value/PE

-

Market value/turnover

2,044

Enterprise value/turnover

2,006

Return ratios

Return on private equity

-

Return on total equity

7,92%

Profit margin

10,70%

Risk ratios

Solvability

-

Solvability

-

Current ratio

1,108

Debt to Equity

-

Value invest ratios

Grahams Number

-

Grahams Value

-

Grahams Product

-

Grahams Product (3 years)

-
2020: Profit and loss

Net profit (x 1 mln)

€ 59,60

Turnover (x 1 mln)

€ 557,16

Cashflow(x 1 mln)

€ 59,60

Net cashflow(x 1 mln)

-

Balance

Private equity (x 1 mln)

-

Foreign equity (x 1 mln)

-

Current assets (x 1 mln)

€ 221,88

Current liabilities (x 1 mln)

€ 200,26

Working capital (x 1 mln)

€ 21,62

Balance total (x 1 mln)

€ 752,83

Share

Outstanding shares (x 1 mln)

72,090

Price year-end

€ 19,00

Dividend per share

€ 0,18

Earnings per share

€ 0,83

Cashflow per share

€ 0,83

Net cashflow per share

-

Book value per share

-

Stockmarket value (x 1 mln)

€ 1.369,71
History: Year

2020

2019

2018

2017

2016

Net profit (x 1 mln)

€ 59,60

€ 41,06

€ 42,49

€ 46,66

€ -20,56

Turnover (x 1 mln)

€ 557,16

€ 536,68

€ 473,40

€ 441,55

€ 425,05

Price year-end

€ 19,00

€ 19,33

€ 14,28

€ 11,42

€ 9,71

Year high

€ 23,26

€ 19,47

€ 17,10

€ 13,74

€ 10,59

Year low

€ 13,85

€ 14,00

€ 10,02

€ 8,84

€ 3,79

Outstanding shares (x 1 mln)

72,090

72,180

71,840

71,840

53,957

Price to Earnings

22,982

33,981

24,144

17,575

-25,490

Earnings per share

€ 0,83

€ 0,57

€ 0,59

€ 0,65

€ -0,38

Dividends

€ 0,18

€ 0,15

€ 0,12

-

-

Dividend yield

0,95%

0,78%

0,84%

-

-

Pay out

21,77%

26,37%

20,29%

-

-

Private equity (x 1 mln)

-

-

-

-

€ 152,88

PE per share

-

-

-

-

€ 2,83

Balance total (x 1 mln)

€ 752,83

€ 801,24

€ 682,77

€ 594,05

€ 852,84

Stockmarket value (x 1 mln)

€ 1.369,71

€ 1.395,24

€ 1.025,88

€ 820,05

€ 524,08
Company analysis: Analysis of profit indicators

Average profit per share (9 years)

€ -0,24

Standard deviation average profit

€ 2,23 (-939,37%)

Average annual growth rate

-28,86%

Compound annual growth percentage

-1,37%

Fagron

Shares

Compare

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.

Ok Decline